— Know what they know.
Not Investment Advice

CTEV NYSE

Claritev Corporation
1W: +1.1% 1M: +0.7% 3M: -3.3% YTD: -33.2% 1Y: -67.5% 3Y: -63.0% 5Y: -88.9%
$22.65
+1.11 (+5.15%)
 
Weekly Expected Move ±8.6%
$19 $21 $24 $26 $28
NYSE · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 40 · $383.9M mcap · 7M float · 2.16% daily turnover · Short 45% of daily vol
Credit Risk of going bust: higher than 96% of companies Debt: 92.7% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $18.94 (down 16%), Claritev Corporation would be worth roughly what it owes.
Total debt $4.62B against a stock market value of $365.0M.
Distance to default 0.10 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $2.32B (short-term plus half of long-term), stock volatility 127.1%; Altman Z'' -1.71. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Revenue Segmentation

By Product / Service

Income Trends

Revenue
$965M +3.7% ▲
5Y CAGR: +0.6%
Gross Profit
$267M -61.4% ▼
5Y CAGR: -15.5%
Operating Income
$45M +103.2% ▲
Net Income
-$284M +82.7% ▲
EPS (Diluted)
$-17.30 +83.0% ▲
EBITDA
$475M +147.2% ▲
5Y CAGR: +19.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$1.1B$1.1B$962M$931M$965M
YoY Growth+19.2%-3.4%-10.9%-3.2%+3.7%
Cost of Revenue$175M$204M$235M$239M$699M
Gross Profit$942M$876M$726M$691M$267M
Gross Margin84.3%81.1%75.5%74.3%27.6%
R&D Expenses$0$0$0$0$0
SG&A Expenses$151M$132M$136M$160M$222M
Operating Expenses$556M$1.2B$564M$2.1B$222M
Operating Income$386M-$363M$162M-$1.4B$45M
Operating Margin34.5%-33.6%16.8%-149.4%4.7%
Interest Expense$267M$303M$333M$326M$400M
Income Before Tax$135M-$561M-$107M-$1.8B-$373M
Tax Expense$33M$12M-$15M-$125M-$89M
Net Income$102M-$573M-$92M-$1.6B-$284M
Net Margin9.1%-53.1%-9.5%-176.9%-29.4%
EPS (Diluted)$6.40$-35.87$-5.69$-101.92$-17.30
EBITDA$815M$158M$652M-$1.0B$475M
Shares Outstanding16M16M16M16M16M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms